tv
US$ 24.13
glp-1 drug least chemical modification GLP-1-based therapies for type 2 diabetes: from single, dual and triple agonists to endogenous production and L-cell differentiation | Diabetology & Metabolic Syndrome GLP-1s are more than just
Description
While generally safe and effective, long-term cardiovascular and immune implications remain understudied and thus represent major unanswered concerns
Sternkopf et al., 2020
FDA-approved titration schedules typically involve 4-8 week intervals between dose increases, allowing physiological adaptation to occur
These medications are usually prescribed off-label if alcohol is the focus, which means insurance coverage is unlikely
Wilding et al
